Find trials
Search tips

A Study Of Cardiac Genetic Pathologic Abnormalities In The Isolated Cardiac Sarcoidosis

Overview

About this study

The purpose of this study is to determine extent of cardiac genetic pathologic abnormalities in the isolated CS population.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 18 years and older

  • Diagnosed at Mayo Clinic with definite, probable or possible CS

  • Pathologic and genetic assessment of CS obtained


Exclusion Criteria:

  • Under the age of 18

  • Unable or unwilling to consent to study participation and genetic testing

  • Anyone who opted out of the Minnesota Research Authorization

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/31/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

John Bois, M.D.

Contact us for the latest status

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20598339

Mayo Clinic Footer